NCT02676323: Panobinostat With Fludarabine and Cytarabine for Treatment of Children With Acute Myeloid Leukemia or Myelodysplastic Syndrome |
|
|
| Terminated | 1 | 19 | US | Panobinostat, LBH589, Fludarabine, Fludara®, Fludarabine phosphate, 2-fluoro-ara-AMP, Cytarabine, Cytosine arabinoside, Ara-C, Cytosar®, Intrathecal Triples, ITMHA, methotrexate/hydrocortisone/cytarabine, Leucovorin, Leucovorin calcium, Leucovorin rescue | St. Jude Children's Research Hospital | Acute Myeloid Leukemia, Myelodysplastic Syndrome | 04/18 | 04/18 | | |
